You are required to be logged in to access the full website
Click here if you have forgotten your username or password
25 May 2026 - Caliway Biopharmaceuticals (TWSE:6919), a Taiwan-based clinical-stage biopharmaceutical company, announced on Friday that it has received approval from the US Food and Drug Administration (FDA) for the Investigational New Drug (IND) app...
25 May 2026 - US biopharmaceutical company AbbVie (NYSE:ABBV) announced on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of MAVIRET (gle...
22 May 2026 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) announced on Friday that Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union as a monotherapy for the treatment of adult patients with unr...
22 May 2026 - French biotechnology company OSE Immunotherapeutics SA (Euronext Paris:OSE) on Friday reported positive topline results from the Phase 2 TEDOVA trial evaluating Tedopi, with or without pembrolizumab, as maintenance therapy for platinum-...
22 May 2026 - Biotechnology company INOVIO (NASDAQ:INO) announced on Thursday that its Chinese partner, ApolloBio, has reported positive topline results from its pivotal Phase 3 trial of VGX-3100, INOVIO's investigational DNA immunotherapy being...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe